Evidence map›Paper›PMID 24713864›Full record

ArticlePloS one2014

Cockayne syndrome: varied requirement of transcription-coupled nucleotide excision repair for the removal of three structurally different adducts from transcribed DNA.

Nataliya Kitsera, Karola Gasteiger, Bork Lühnsdorf, Julia Allgayer, Bernd Epe, Thomas Carell, Andriy Khobta

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. DNA damage during the G0/G1 phase triggers RNA-templated, Cockayne syndrome B-dependent homologous recombination.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Nataliya KitseraInstitute of Pharmacy and Biochemistry, Johannes Gutenberg University of Mainz, Mainz, Germany.
Karola GasteigerDepartment of Chemistry and Biochemistry, Ludwig-Maximilians University Munich, Munich, Germany.
Bork LühnsdorfInstitute of Pharmacy and Biochemistry, Johannes Gutenberg University of Mainz, Mainz, Germany.
Julia AllgayerInstitute of Pharmacy and Biochemistry, Johannes Gutenberg University of Mainz, Mainz, Germany.
Bernd EpeInstitute of Pharmacy and Biochemistry, Johannes Gutenberg University of Mainz, Mainz, Germany.
Thomas CarellDepartment of Chemistry and Biochemistry, Ludwig-Maximilians University Munich, Munich, Germany.
Andriy KhobtaInstitute of Pharmacy and Biochemistry, Johannes Gutenberg University of Mainz, Mainz, Germany.
Johannes Gutenberg University Mainz · DELudwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary defects in the transcription-coupled nucleotide excision repair (TC-NER) pathway of damaged DNA cause severe neurodegenerative disease Cockayne syndrome (CS), however the origin and chemical nature of the underlying DNA damage had remained unknown. To find out, to which degree the structural properties of DNA lesions determine the extent of transcription arrest in human CS cells, we performed quantitative host cell reactivation analyses of expression vectors containing various synthetic adducts. We found that a single 3-(deoxyguanosin-N2-yl)-2-acetylaminofluorene adduct (dG(N2)-AAF) constitutes an unsurmountable obstacle to transcription in both CS-A and CS-B cells and is removed exclusively by the CSA- and CSB-dependent pathway. In contrast, contribution of the CS proteins to the removal of two other transcription-blocking DNA lesions - N-(deoxyguanosin-8-yl)-2-acetylaminofluorene (dG(C8)-AAF) and cyclobutane thymine-thymine (TT) dimer - is only minor (TT dimer) or none (dG(C8)-AAF). The unique properties of dG(N2)-AAF identify this adduct as a prototype for a new class of DNA lesions that escape the alternative global genome repair and could be critical for the CS pathogenesis.

Indexed as

DNA AdductsDNA RepairTranscription, GeneticCell LineCockayne SyndromeDeoxyguanosineDNA HelicasesDNA Repair EnzymesFluorenesGene Expression RegulationGene SilencingGenes, ReporterHumansPoly-ADP-Ribose Binding Proteins3-(deoxyguanosin-N2-yl)-2-acetylaminofluoreneDeoxyguanosineDNA AdductsDNA HelicasesDNA Repair EnzymesERCC6 protein, humanFluorenesPoly-ADP-Ribose Binding Proteins

Identifiers

PMID24713864
PMCPMC3979923
OpenAlexW2058151233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.